Thank you!
Your support is sustaining the future of local news in our communities.

How will the COVID pandemic end?

In an extraordinary 20 months, science has tackled the SARS-CoV-2 virus and made vaccines for adults and children. Scientists have developed monoclonal antibodies that help if given early; we now have the first drugs that could stop infections or tilt the immunological fight in favor of the patient. The number of COVID cases is going down, although in some areas like the mountain West the disease is still raging. The virus is an opportunist. Remember the 750,000 people in the United States and the millions around the world who have died.

People go without vaccines for various reasons that we know by now. People who refuse vaccines may not understand that “Fortune favors the prepared immune system,” to paraphrase Louis Pasteur’s “Fortune favors the prepared mind.” A 50-microgram injection induces antibodies that neutralize the SARS-CoV-2 coronavirus or T-cells that kill the human cells, which contain multiplying virus.  As the vaccines’ protection wanes over six months, a few elderly people in their 80s or older have died of COVID infections. The late waning can be corrected by boosters, or at least I hope so.

The grizzly experiment to test the SARS-CoV-2 vaccines has been done in Texas, Florida, Louisiana and other places where the level of vaccination is low. The virus, or more recently the delta variant, raced through the population, filling wards with COVID patients. A year-and-a-half after this disaster hit New York hospitals, other hospitals in the West and South, Alaska and other places are converting space to treating COVID-19 patients. More than 90% of their patients in intensive care were not vaccinated. Anti-vaxxers do not usually plan clinical trials, but in this case, inadvertently, they did. The vaccine protects people.

Predicting the end of the pandemic is a tricky business. We thought we had seen the end in June and July. Then, with the delta variants, the trend reversed among unvaccinated people and cases went up. Could there be more variants? Yes, but so far, the vaccines have worked against all variants. Antibodies and T-cells react with all parts of a virus protein, not just the sections that have changed in the variants.

What does medicine have to throw into this battle?  Monoclonal antibodies are being used and they work if applied early in the disease. These antibodies are produced in fermenters and must be infused intravenously. They are expensive and tricky to use. Fighting an epidemic, especially in poor areas of the world and of the United States, demands simplicity.

There is a drug, malnupiravir, that if given early in an infection often controls it. It was developed at Emory University in Atlanta and licensed to Merck for production. Malnupiravir is a cleverly designed molecule that gets incorporated into new viruses and mutates them out of existence.  It has been approved for use in the United Kingdom. It may block infection in people who have been exposed to the virus. That will be known soon. Merck will not enforce patent restrictions.

Pfizer also has a promising drug that works by a mechanism that is different from that of malnupiravir. The difference is important because viruses often mutate to become resistant to one oral drug. In the case of HIV, several drugs were required to stop infection. Pfizer’s drug is also well along in phase 3 clinical trials and may soon receive an Emergency Use Authorization.

Excited journalists are writing about these drugs as game changers, but that is premature. A drug or combinations of drugs must have changed the game to be called a game changer. On a population basis, that remains to be seen. I am hopeful, but a little caution is in order. On a more hopeful note, drugs like these have worked for HIV, Hepatis C virus, and Dengue virus. Producing and distributing these drugs for the whole world will take time.

My prediction is that COVID-19 will recede in areas of high vaccination. All treatments will have a role, but vaccination will play the primary one. In areas where vaccination rates are low, say 40%, there will be serious problems with high levels of infection and overwhelmed medical facilities for extended periods. That patient load affects a hospital’s ability to treat other diseases. The poor and medically underserved will get even less attention. Schools, industry, and the economy are weakened. Society becomes very cranky, even violent. The vaccines, and perhaps the drugs, offer an off ramp from this disaster.

Richard Kessin lives in Norfolk and is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center. See other essays at RichardKessin.com or at The Lakeville Journal. www.tricornernews.com/category/opinion-author/body-scientific. E-mail: Richard.Kessin@gmail.com.

The views expressed here are not necessarily those of The Lakeville Journal and The Journal does not support or oppose candidates for public office.

Latest News

Residents tear down Patriot Front signs in North Canaan and Falls Village

A Patriot Front sign hangs in front of the Canfield Building on Main Street in North Canaan on Wednesday, Nov. 11. The sign was removed later that day.

Madi Long

NORTH CANAAN — Residents in North Canaan and Falls Village have taken down signs bearing the name Patriot Front, which the Southern Poverty Law Center classifies as a white nationalist hate group.Connecticut State Police said they referred two incidents to hate crimes investigators.

On Nov. 2, a Troop B sergeant spotted a sign on a utility pole near Route 7 and North Elm Street. State police contacted the utility company, which took down the sign.

Keep ReadingShow less

Sharon revisits speed cameras, weighs humps

Sharon revisits speed cameras, weighs humps
A speed camera in Washington, Conn. Sharon selectmen have discussed installing similar cameras.
Alec Linden

SHARON — A group of more than 20 residents who live along Jewett Hill Road has petitioned the town to install speed humps on their roadway. Jewett Hill Road runs less than a mile between Calkinstown Road and Jackson Hill Road.

The petition prompted a broader discussion about speeding at the Sharon Board of Selectmen meeting on Nov. 10. First Selectman Casey Flanagan said he plans to revive an earlier proposal to use speed cameras on town roads and resume talks with an installation company.

Keep ReadingShow less
North Canaan recovers $15,000 in nip fees sent to New Canaan
North Canaan Town Hall
File photo

NORTH CANAAN — The town has recovered $15,000 in lost revenue from a surcharge on miniature liquor bottles after Treasurer Melanie Neely discovered that the money had mistakenly been sent to New Canaan.

First Selectman Jesse Bunce announced the recovery at the Nov. 9 Board of Selectmen meeting, drawing a round of applause. Bunce investigated the discrepancy after Neely brought it to his attention.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Northwest Corner veterans help one another get care

Couch-Pipa VFW Post 6851

Patrick Stachniak

NORTH CANAAN — As the flags from Veterans Day parades are furled and the public tributes fade, veterans in Connecticut’s rural Northwest Corner still face the quieter work of finding care and talking about the pain and anguish they brought home.

Those challenges can become more acute as winter and the holidays approach, said Keith Appleton, an Army veteran and licensed master social worker at Mountainside Treatment Center.

Keep ReadingShow less
Northwest Corner honors veterans at schools and memorials

Local veterans salute during the Veterans Day ceremony in Kent.

Ruth Epstein

NORTHWEST CORNER — Students, veterans and neighbors across the Northwest Corner marked Veterans Day with school assemblies and ceremonies at town memorials.

Salisbury Central School held its assembly Tuesday, Nov. 10. Schools in Falls Village, Cornwall, Sharon and Kent also observed the holiday.

Keep ReadingShow less
Salisbury’s median home sale price rises 5% to $920,000

This four-bedroom house at 175 Main St. in Salisbury sold for $990,000 on Sept. 30. It sold for $1,025,000 in January 2022.

Christine Bates

SALISBURY — The median sale price of a single-family home in Salisbury rose to $920,000 for the 12 months ended Oct. 31, up 5.1% from $875,000 a year earlier and 6.4% from $865,000 for the same period in 2024. The figures exclude condominiums.

The rolling 12-month median peaked at $1.35 million in May 2025 and fell to $775,000 at the start of 2026. It has remained above $900,000 since July.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.